Jahangir Mir

About

I’m Jahangir Nabi, a pharmacy professional with over 7 years of experience in the Health Economics and Outcomes Research (HEOR) field. I hold a master’s degree in pharmacology, focusing on neurosciences and behavior, from the Delhi Institute of Pharmaceutical Sciences and Research, New Delhi. Over the years, I’ve developed expertise in systematic and targeted literature reviews, meta-analysis, and network meta-analysis. I specialize in analyzing clinical, economic, burden-of-illness, and quality-of-life data, which helps in shaping value communication through Global Value Dossiers (GVDs), Health Technology Assessments (HTAs), and Real-World Evidence (RWE) studies.

Currently, I’m working as a Consultant at IQVIA, where I’ve had the opportunity to grow through various roles. My work mainly involves medical and scientific writing, supporting evidence generation, and delivering comprehensive analyses that inform healthcare decisions. I’ve also published papers on diverse topics.

I’m proud to have been recognized for my contributions with multiple Bronze and Silver awards under IQVIA's Impact Program.

Employment

• IQVIA Consultant
  2022 - Present
• IQVIA Associate consultant
  2020 - 2022
• IQVIA Analyst
  2017 - 2020
• IQVIA India Intern
  2017 - 2017

Education

Education history is unavailable.

Projects & Funding

Projects & funding information is unavailable.

Publications (19)

• The burden of hyperkalaemia in chronic kidney disease: a systematic literature review
  Clinical Kidney Journal 2025 DOI: 10.1093/ckj/sfaf127
  +Save
• A Systematic Literature Review of the Humanistic, Economic, Sociodemographic, and Environmental Burden Associated with Severe COPD
  International Journal of Chronic Obstructive Pulmonary Disease 2025 DOI: 10.2147/COPD.S510623
  +Save
• Molecular Chaperones in Neurodegeneration
  2020 DOI: 10.4018/978-1-7998-1317-0.ch014
  +Save
• Protein Quality Control in Neurodegeneration and Neuroprotection
  2020 DOI: 10.4018/978-1-7998-1317-0.ch001
  +Save
• Systematic Literature Review of the Efficacy and Safety of Infigratinib for the Treatment of Advanced Cholangiocarcinoma
  +Save
• Protein Quality Control in Neurodegeneration and Neuroprotection
  +Save
• Healthcare Associated Infections: A Global Threat
  Epidemiology and Transmission of Infectious Diseases Dr.
  +Save
• Familial Hypercholesterolemia and Risk of Cardiovascular Disease: A Systematic Literature Review and Meta-Analysis of Observational Studies
  +Save
• Efficacy and Safety of Itolizumab for the Treatment of Coronavirus Disease (COVID-19): A Systematic Literature Review
  +Save
• Efficacy and Safety of Daridorexant in Patients With Insomnia: Systematic Review & Meta-Analysis of Randomized Controlled Trials
  +Save